Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q4 2025 Earnings Call Transcript January 30, 2026 Regeneron Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $11.44, expectations were ...

Charter Communications, Inc. (NASDAQ:CHTR) Q4 2025 Earnings Call Transcript January 30, 2026 Charter Communications, Inc. misses on earnings expectations. Reported EPS is $10.34 EPS, expectations were ...

FDA approved Novo Nordisk’s oral Wegovy pill for obesity and cardiovascular risk reduction, followed by a successful U.S. launch. The company announced plans to reduce its workforce by 9,000 roles as ...

Sanofi’s Rezurock Receives Positive CHMP Recommendation, Advancing New Treatment Option for Chronic GVHD in Europe ...

ME Therapeutics Holdings Inc. ("ME Therapeutics" or the "Company") (CSE: METX) (FSE: Q9T), a publicly listed biotechnology ...

Union Budget 2026 is set for February 1. Experts expect focus on jobs, agriculture, MSMEs, green energy, EVs, healthcare, ...

The Justice Department on Friday released more than 3 million pages of files related to the investigation into sex offender and accused sex trafficker Jeffrey Epstein, after Congress passed a law last ...

Data identify nuclear PD-L1 as a previously unaddressed driver of immunotherapy resistance and metastatic progression ...

A new drug application (NDA) has been submitted to the FDA seeking approval of lirafugratinib (RLY-4008), a selective FGFR2 ...

In a new letter Friday, Attorney General Pam Bondi and Deputy Attorney General Todd Blanche made clear that they believe the DOJ had fulfilled its obligations under the Epstein Files Transparency Act ...

Discover J&J’s pipeline strategy for 2026 as it it projects that its sales for the year will be between $100 billion and $101 ...

Incyte today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) ...